Zhao, W., Yang, H., Huang, H., Zhang, L., Jin, J., Li, W., Jing, H., Li, F., Zhou, S., Liu, T., Li, Y., Li, C., Zou, L., Vindeloev, S. D., Yin, T., Chen, X., Moureaud, C., Jiang, T. (2025). First data from phase 1b/2 EPCORE NHL-4: Epcoritamab (Epcor) in Chinese patients (Pts) with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e19001